Table 2:

Clinical data commonly used as prognostic factors for the 25 patients with ALS

Clinical DataPatients with ALS
Baseline1-Year Follow-Up Subgroup
Body mass index at MRI (± SD)23.7 ± 2.724.0 ± 2.7
Familial transmission2 SOD1 mutated1 SOD1 mutated
Site of onset1 bulbar; 18 upper; 6 lower1 bulbar; 12 upper; 6 lower
Delay from first symptom to diagnosis, mo ± SD9.9 ± 5.610.7 ± 6.0
  • Note:SOD1 indicates SuperOxide Dismutase 1 gene.